Daybue Oral Solution Dosage
Generic name: trofinetide 200mg in 1mL
Dosage form: oral solution
Drug class: Miscellaneous central nervous system agents
Medically reviewed by Drugs.com. Last updated on Mar 29, 2023.
Dosing Information
Administer DAYBUE orally twice daily, in the morning and evening, according to patient weight as shown in Table 1. DAYBUE can be taken with or without food.
Patient Weight | DAYBUE Dosage | DAYBUE Volume |
---|---|---|
9 kg to less than 12 kg | 5,000 mg twice daily | 25 mL twice daily |
12 kg to less than 20 kg | 6,000 mg twice daily | 30 mL twice daily |
20 kg to less than 35 kg | 8,000 mg twice daily | 40 mL twice daily |
35 kg to less than 50 kg | 10,000 mg twice daily | 50 mL twice daily |
50 kg or more | 12,000 mg twice daily | 60 mL twice daily |
Administration Information
Administer DAYBUE orally or via gastrostomy (G) tube; doses administered via gastrojejunal (GJ) tubes must be administered through the G-port.
A calibrated measuring device, such as an oral syringe or oral dosing cup, should be obtained from the pharmacy to measure and deliver the prescribed dose accurately. A household measuring cup is not an adequate measuring device.
Discard any unused DAYBUE oral solution after 14 days of first opening the bottle [see How Supplied/Storage and Handling (16.2)].
Missed Dose or Vomiting After Administration
If a dose of DAYBUE is missed, the next dose should be taken as scheduled. Doses should not be doubled.
If vomiting occurs after DAYBUE administration, an additional dose should not be taken. Instead, continue with the next scheduled dose.
Dose Modification for Diarrhea or Weight Loss
Advise patients to stop laxatives before starting DAYBUE. Interrupt, reduce the dosage, or discontinue DAYBUE if severe diarrhea occurs, if dehydration is suspected, or if significant weight loss occurs [see Warnings and Precautions (5.1, 5.2)].
More about Daybue (trofinetide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.